Journal of Chemistry

Journal of Chemistry / 2019 / Article

Research Article | Open Access

Volume 2019 |Article ID 5375670 |

Qi Liao, Lan Jiang, Cong Li, Yaling Shen, Min Wang, Chengkun Cao, Xiangnan Hu, "An Efficient and Practical Method for the Synthesis of Saxagliptin Intermediate 2-(3-Hydroxy-1-adamantane)-2-oxoacetic Acid and Its Optimization", Journal of Chemistry, vol. 2019, Article ID 5375670, 8 pages, 2019.

An Efficient and Practical Method for the Synthesis of Saxagliptin Intermediate 2-(3-Hydroxy-1-adamantane)-2-oxoacetic Acid and Its Optimization

Academic Editor: Gabriel Navarrete-Vazquez
Received28 Jun 2019
Accepted13 Sep 2019
Published10 Oct 2019


A mild and relatively simple way for preparation of 2-(3-hydroxy-1-adamantane)-2-oxoacetic acid (I) was reported. It was prepared from 1-adamantanecarboxylic acid (II) via sulfuric acid/nitric acid to get 3-hydroxy-1-adamantanecarboxylic acid (III); treated with the one-pot method through acylation, condensation, and decarboxylation to obtain 3-hydroxy-1-acetyladamantane (IV); and finally oxidized by potassium permanganate (KMnO4) to get the target compound (I). The overall yield was about 60%, which provides a new idea for commercial production of saxagliptin intermediate.

1. Introduction

Diabetes, a complex and chronic illness, is becoming a public health problem and even a global societal catastrophe. According to the figures displayed in the 8th edition of the Diabetes Atlas issued by the International Diabetes Federation, until 2017, there were about 451 million adults who lived with diabetes all over the world, and this number may rise to 693 million in 2045, if nothing is done [1].

Dipeptidyl peptidase-4 (DPP-4) inhibitors are classic antihyperglycemic agents used worldwide [2]. Up-to-date studies and analysis reveal clearly that the overall tolerance/safety profile of DPP-4 inhibitors appears better than that of other oral glucose-lowering agents [3]. Compared with sulfonylureas etc., DPP-4 inhibitors may represent a cost-effective option [4].

Saxagliptin (Onglyza) is a highly potent and selective DPP-4 inhibitor authorized by FDA in 2009 [5]. Due to its distinctive mechanism of action and a series of clinical trials, FDA approved its combination with metformin (Kombiglyze XR) and dapagliflozin (Qtern) in 2010 and 2017 [6].

Through retrosynthesis analysis, we found that (S)-N-Boc-3-hydroxyadamantylglycine is a key intermediate of Saxagliptin [7], and it can be prepared economically and efficiently from 2-(3-hydroxy-1-adamantyl)-2-oxoacetic acid (I) by asymmetric reductive amination [8, 9] (Figure 1).

Not surprising, much effort has been made to synthesize this essential intermediate I (Figure 2). Politino et al. [10] originally describe a method treating 1-bromoadamantane as starting material, which reacted with silane coupling agent to give α hydroxy acid and then through esterification, Swern oxidation, hydroxylation, and hydrolysis to produce the target compound I. However, harsh reaction conditions involved in Swern oxidation (−78°C) restrict the route for commercial manufacturing.

Henryon et al. [11] developed an improved route to start with 1-adamantanecarboxylic acid, which was acylated by thionyl chloride (SOCl2) and substituted by cyanide reagent TMSCN to afford cyanide and then underwent hydrolysis, esterification, and hydroxylation to obtain the intermediate. But it was found that this route demanded greatly multiple procedures as well as relatively complex operation. Furthermore, the overall yields were unsatisfactory (28%) and thus were not adequate for implementation of a large-scale work.

Our team [12] reported a method to prepare the target compound. Regarded 1-adamantanecarboxylic acid as raw material which was methylated by the one-pot method to obtain 1-acetyladamantane and afterwards through oxidation and hydroxylation to acquire compound I. The scheme we came up with required inexpensively acceptable materials and mild reaction conditions. But the yield of hydroxylation is relatively low (68%) which limited the application to industrial production.

In in-depth study, we found that the hydroxylation of adamantane tertiary carbon was the key factor affecting the total yield. A series of methods were reported, but the results were disappointed (Figure 3). Berner et al. [13], using 1-acetyladamantane as the first material via one-step oxidation, introduced the hydroxyl and carboxyl group (36%). Li et al.[12] used two-step oxidation and hydroxylation in the second step, but they did not get the good result(61%). Wilhelm et al. [14] made 1-adamantane glycine as the raw material hydroxyl, but the yields are still low (66%). Venkat et al. [15] protected the amino group; however, the hydroxylation yields lower (40%). Bertolini et al. [16] kept hydroxylation as the last step of Saxagliptin synthesis, but the yields are still low (74%).

To sum up, it seems to delay the hydroxylation step always to reduce the yield. Our team analyzed the reason for the low yield. We believe that the key to solve the problem should be on the adamantane ring. The nature of hydroxylation is adamantane oxidation. Due to the presence of electron-withdrawing substituents, electron-withdrawing effects may decrease the cloud density of the adamantane ring and cause difficulty in oxidation. On the other hand, the spatial effect may also increase steric hindrance, making it difficult for oxidants to fully react with raw materials and lead to low yields. Thus, if we change the oxidation sequence and advance the hydroxylation to avoid the above problems, it may be a feasible way to increase the yield.

2. Results and Discussion

On account of the above hypothesis, we made some improvements based on our laboratory previous work [12, 17, 18] and developed an efficient and practical method for the synthesis of I. The specific improvements of route are depicted in Figure 4:

It was prepared from 1-adamantanecarboxylic acid (II) via sulfuric acid/nitric acid to get 3-hydroxy-1-adamantanecarboxylic acid (III); treated with the one-pot method through acylation, condensation, and decarboxylation to obtain 3-hydroxy-1-acetyladamantane (IV); and finally oxidized by potassium permanganate (KMnO4) to get the target compound (I).

In the process optimization, we focused on the synthesis of IV and I. In the one-pot method step synthesis of IV, we used acetyl chloride (CH3COCl) with lower activity instead of SOCl2, aiming to shorten the duration of reactions and improve production efficiency (Figure 5) because the latter also led to chlorination of 3-hydroxy to form the byproduct, which would increase our workload (Figure 6). In addition, we optimized the step of acylation reaction via central composite design-response surface methodology concentrate upon four vital factors after single factor experiment study of 3-hydroxy-1-acetyladamantane [19].

Furthermore, the species of catalyst used in the synthesis of I was screened, which represented a great improvement compared with our previous work that increased the reaction yield effectively. The optimized reaction conditions shortened the reaction time, saved cost, and gave the target compound with 60% yield, which was suitable for industrial production.

Central composite design-response surface methodology has been widely used for process optimization in recent years, which has the advantages of high precision and good predictability and being sensitive to examine the interaction between the various factors [20, 21]. In the step of acylation reaction, it was used to summarize the key factors affecting the experiment, which optimized the experimental conditions and achieve a better result.

The factors influencing the yield of compound IV were as follows: the species of the catalyst (Table 1), the catalyst loading (Figure 7), the mole ratio of acetyl chloride to compound III (Figure 8), reaction temperature (Figure 9), and reaction time (Figure 10). Therefore, the five factors above were set to several levels in the pre-experiment and used single factor experiment study to investigate the effects of them on the yield of compound IV. The specific result is shown below.

CatalystThe feed ratios of the catalyst to raw materials (mol/mol)The yield of compound IV (%)


After confirming the preliminary range of the variables via single-factor experiment, a central composite design-response surface methodology with four independent factors (Xa, molar ratio of acetyl chloride to compound 3; Xb, reaction time; Xc, reaction temperature; and Xd, the pyridine loading) at five levels was performed. For statistical calculation, the levels were coded as −2, −1, 0, +1, and +2, respectively, in which −2 corresponds to the low level of each factor, +2 to the high level, and 0 to the midlevel. The result of central composite design-response surface methodology is described in Table 2. As seen from Table 2, the complete design consisted of 30 experimental points, and the experiment was carried out in a random order. Each factor has been implemented multiple linear regression and binomial fitting via the software of Design-Expert 8.0.6 [18].

NumberX a (mol/mol)X b (h)X c (°C)X d (g)Actual yield (%)


Multiple linear regression equation was

The binomial equation was

From the equation above, the correlation coefficient of binomial equation (r2) was bigger than multiple linear regression (r1) which means the actual values were well in close agreement with the predicted values, so we chose that the binomial model was the better one ultimately.

According to the obtained binomial equation, the corresponding 3-D response surface plot of compound IV is depicted in Figure 11. As shown in Figure 11, within limits, the yield rose as the molar ratio of acetyl chloride to compound III rose, reaction time prolonged, reaction temperature increased, and the pyridine loading enhanced and then reached the maximum value, but beyond a certain level, the yield decreased. Each response surface has its optimal interval, and higher yields could be obtained when the reaction conditions were in the region, via overlapped the optimal region of each response surface, optimized range of producing compound 6 was obtained as shown below: Xa: 2.9 : 1∼3.4 : 1; Xb: 3∼4 h; Xc: 30∼55°C; and Xd: 1.4∼1.6 g.

However, with a view to operation of the process and input-output ratio, the final reaction conditions we selected among the above ranges were: The molar ratio of acetyl chloride to compound III (3.1 : 1), reaction time (4 h), reaction temperature (40°C), and the pyridine loading(1.5 g). Finally, we performed five parallel experiments under the optimized reaction conditions, and compound IV was obtained in 74.3%, 72.5%, 73.1%, 73.5%, and 72.0% yields, respectively, with the purity reaching to 99%. The average yield was 73.1% with a deviation of 0.66%.

As for the oxidation step, Cheng et al. [22] reported a method that treated 1-acetyladamantane with potassium permanganate in pyridine to get the target compound; however, pyridine is poisonous. So, we used nontoxic t-butanol instead of pyridine. In addition, considering that 1-acetyladamantane and potassium permanganate are not easily soluble in t-butanol, the phase transfer catalyst (PTC) was added to improve the two-phase reaction system [23, 24]. The types of PTC were also examined; we fixed the mole ratio of PTC to compound IV to 1 : 20, reaction time to 2.5 h, reaction temperature to 40°C, and the mole ratio of potassium permanganate to compound IV to 1.5 : 1, to investigate the influence of PTC species on the yields (Table 3).

Phase transfer catalystThe yield of compound I (%)


As shown in Table 3, the addition of phase transfer catalyst can improve the reaction yield obviously. TBAB was a good choice which raised the yield to 91%; therefore, TBAB was added to the reaction solution to shorten the reaction time and improve the yield.

3. Experimental

All reagents were purchased commercially and were used as supplied unless otherwise specified. Melting points were determined through SGW X-4 micromelting point apparatus. IR was recorded using a Nicolet FTIR 5700 spectrophotometer, ESI-MS spectra were recorded from a Finnigan LCQ Advantage Max spectrometer, and 1H-NMR was recorded on a Bruker Avance III 600 MHz spectrometer.

3.1. Preparation of 3-Hydroxy-1-adamantanecarboxylic Acid (III)

A 150 mL three-necked round bottom flask was equipped with magnetic stirrer and thermometer. The flask was charged with sulfuric acid (98%, 20 mL) and nitric acid (65%, 2 mL) in turn. The mixed acid was stirred at 0°C for 1 h, followed by addition of 1-adamantanecarboxylic acid (5.0 g, 0.028 mol) in portions within 0.5 h while maintaining the temperature at 0°C. Thereafter, the reaction mixture was stirred at room temperature for 12 hrs. Water (125 mL) was added to the reaction mixture and stirred for 5 hrs. Then, the suspension was filtered, and the filter cake was recrystallized with propanone/water and dried over Na2SO4 to afford purified compound III (4.90 g, 90.0% yield). M.p. 199∼200°C (lit. [18] 199∼200°C); IR (KBr, cm−1): 3460, 2850, 1680, 1200, 1100, 600; 1H NMR (600 MHz, DMSO-d6) δ: 11.89 (br s, 1H, COOH), 4.50 (br s, 1H, OH), 2.12∼2.14 (m, 2H, CH), 1.66∼1.48 (m, 12H, CH2); ESI-MS (m/z): 197 (M + 1)+.

3.2. Preparation of 3-Hydroxy-1-acetyladamantane (IV)

A mixture of pyridine (4.5 mL, 0.056 mol) and compound III (5.5 g, 0.028 mol) was stirred in an ice-water bath for an hour; then, acetyl chloride (10 mL, 0.138 mol) was added dropwise to the mixture, and this solution was stirred at 25°C for 3 h. After that, pyridine hydrochloride was formed and was filtered. The excess acetyl chloride of filtrate was removed with reduced pressure, and the residue was 3-hydroxy-1-adamantyl methacetic anhydride. A mixture of diethyl malonate (7.4 mL, 0.042 mol) and petroleum ether (20 ml) were added dropwise to metallic sodium in petroleum ether (100 mL). The mixture was stirred for another 15 h at room temperature to get white precipitates. Afterwards, previously prepared 3-hydroxy-1-adamantyl methacetic anhydride in petroleum ether (20 mL) was added to the preceding suspension slowly; then, the mixture was stirred at room temperature for 12 h. Afterwards, water (50 ml) was added to the solution and stirred for about 10 minutes, and the organic layers were separated and concentrated with reduced pressure to give the oil residue. After that, a mixed solution of acetic acid (20 ml), water (6 ml), and sulfuric acid (2 mL) was added to the residue obtained as above, the reaction mixture was then refluxed for 8 h and then poured into cold water (200 mL), which was extracted with ethyl acetate (3 × 10 mL), and the combined organic layers were washed with water (100 mL), dried over Na2SO4, and concentrated under reduced pressure. The residue was recrystallized from methylene chloride/hexane to give compound IV (3.69 g, 74.6% yield).M.p. 89∼90°C(lit. [25] 89∼90°C); IR (KBr, cm−1): 3380, 2880, 2850, 1750, 1410, 1000, 600; 1H NMR (600 MHz, DMSO-d6) δ: 4.52 (s, 1H, OH), 2.22 (br s, 2H, CH), 2.05 (s, 3H, CH3), 1.62∼1.47 (m, 12H, CH2); ESI-MS (m/z): 195 (M + 1)+.

3.3. Preparation of 2-(3-Hydroxy-1-adamantyl)-2-Oxoacetic Acid (I)

The tert-butanol (10 mL), 2% KOH (100 mL), compound IV (5.0 g, 0.026 mol), and phase transfer catalyst TBAB were added to a 250 mL three-necked flask; then, the mixture was stirred at 40°C, and potassium permanganate (8.3 g, 0.052 mol) was added in batches during a period of 1 h. After that, the solution was stirred for 5 h; then, sodium sulfite (3.8 g, 0.026 mol) was added and stirred for 10 min, and the mixture was filtered. The filtrate was adjusted to pH 1-2 and then extracted with ethyl acetate (10 mL × 3), and the organic phases were combined, which was concentrated under reduced pressure to get a light yellow oil residue. The residue was recrystallized by heptane and dried to obtain compound I (5.3 g, 91.8% yield). M.p. 163–165°C (lit. [26] 164∼165°C); IR (KBr, cm−1): 3380, 2920, 2850, 1713, 1680; 1H NMR (600 MHz, DMSO-d6) δ: 14.2 (br s, 1H, COOH), 4.6 (br s, 1H, OH), 2.19 (s, 2H, CH), 1.72–1.46 (m, 12H, CH2); ESI–MS (m/z): 225(M + 1)+.

4. Conclusion

This study provides a simple and economical method to synthesis 2-(3-hydroxy-1-adamantane)-2-oxoacetic acid in 60% yield from 1-adamantanecarboxylic acid over five steps. The reaction is mild, simple, and inexpensive, which represents a great improvement compared with previously reported methods and has a great foreground of development.

Data Availability

The figure and table data used to support the findings of this study are included within the article.

Conflicts of Interest

The authors declare that there are no conflicts of interest regarding the publication of this paper.

Authors’ Contributions

Qi Liao and Lan Jiang have contributed equally to this work.


The authors are deeply grateful for the support of the Chongqing Science and Technology Commission (cstc2015zdcy-ztzx120003) for this study. The authors also appreciate that the Undergraduate Innovative Experiment Program of Chongqing Medical University (no. 201971) for providing financial aid for our work.


  1. N. H. Cho, J. E. Shaw, S. Karuranga et al., “IDF diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045,” Diabetes Research and Clinical Practice, vol. 138, pp. 271–281, 2018. View at: Publisher Site | Google Scholar
  2. M. Long, L. Cai, W. Li et al., “DPP-4 inhibitors improve diabetic wound healing via direct and indirect promotion of epithelial-mesenchymal transition and reduction of scarring,” Diabetes, vol. 67, no. 3, pp. 518–531, 2018. View at: Publisher Site | Google Scholar
  3. A. J. Scheen, “Safety of dipeptidyl peptidase-4 inhibitors for treating type 2 diabetes,” Expert Opinion on Drug Safety, vol. 14, no. 4, pp. 505–524, 2015. View at: Publisher Site | Google Scholar
  4. J. Geng, H. Yu, Y. Mao, P. Zhang, and Y. Chen, “Cost effectiveness of dipeptidyl peptidase-4 inhibitors for type 2 diabetes,” Pharmacoeconomics, vol. 33, no. 6, pp. 581–597, 2015. View at: Publisher Site | Google Scholar
  5. S. Dhillon, “Saxagliptin: a review in type 2 diabetes,” Drugs, vol. 75, no. 15, pp. 1783–1796, 2015. View at: Publisher Site | Google Scholar
  6. G. Mospan, C. Mospan, S. Vance, A. Bradshaw, K. Meosky, and K. Bowles, “Drug updates and approvals,” The Nurse Practitioner, vol. 42, no. 12, pp. 8–16, 2017. View at: Publisher Site | Google Scholar
  7. S. A. Savage, G. S. Jones, S. Kolotuchin, S. A. Ramrattan, T. Vu, and R. E. Waltermire, “Preparation of saxagliptin, a novel DPP-IV inhibitor,” Organic Process Research & Development, vol. 13, no. 6, pp. 1169–1176, 2009. View at: Publisher Site | Google Scholar
  8. C. V. Truc, D. B. Brzozowski, R. Fox et al., “Methods and compounds for producing dipeptidyl peptidase IV inhibitors and intermediates,” 2005, EP 2792672A3. View at: Google Scholar
  9. L. H. Ronald, L. G. Steven, B. B. David et al., “Preparation of an amino acid intermediate for the dipeptidyl peptidase IV inhibitor, saxagliptin, using a modified phenylalanine dehydrogenase,” Advanced Synthesis & Catalysis, vol. 349, no. 8-9, pp. 1369–1378, 2010. View at: Publisher Site | Google Scholar
  10. M. Politino, M. M. Cadin, P. M. Skonezny et al., “Process for preparing dipeptidyl IV inhibitors and intermediates,” 2005, EP 1737970. View at: Google Scholar
  11. V. Henryon, J. Monbrun, and M. Casado, “Method for producing adamantyl compounds: WO,” 2010, WO/2010/032129. View at: Google Scholar
  12. J. Li, S. Zhang, H. Zhou, J. Peng, Y. Feng, and X. Hu, “Preparation of 2-(3-hydroxy-1-adamantyl)-2-oxoacetic acid: a key intermediate for saxagliptin,” Letters in Organic Chemistry, vol. 9, no. 5, pp. 347–350, 2012. View at: Publisher Site | Google Scholar
  13. M. Berner, R. Partanen, A. Salakka et al., “Process for the preparation of adamantane derivatives,” 2007, US Patent 7205432. View at: Google Scholar
  14. T. Wilhelm, K. Knepper, W. Felzmann et al., “Process for the reductive amination of α-keto carboxylic acids,” 2012, WO/2012/028721. View at: Google Scholar
  15. R. Venkat, M. Raghu, K. Ajay et al., “A process for industrial preparation of [(S)-N-tert butoxycarbonyl-3-hydroxy] adamantyl glycine,” 2014, WO 2014057495. View at: Google Scholar
  16. G. Bertolini, M. Sada, S. Maiorana et al., “Process for the preparation of intermediates of synthesis of saxagliptin and novel compounds,” 2014, WO2014/118612. View at: Google Scholar
  17. R. Gan, M. Zhang, J. Li et al., “Synthesis of 2-(3-hydroxy-1-adamantyl)-2-oxoacetic acid,” Chinese Journal of Pharmaceuticals, vol. 47, no. 10, pp. 131–133, 2016. View at: Google Scholar
  18. J. Li, X. Jiang, R. Gan et al., “A facile and economic method for the synthesis of (S)-N-Boc-3-hydroxyadamantylglycine,” Research on Chemical Intermediates, vol. 42, no. 6, pp. 1–13, 2016. View at: Publisher Site | Google Scholar
  19. M. Basri, M. A. Alrub, E. A. Malek, S. Ainliah, A. B. Salleh, and M. B. Abdul Rahman, “Optimization of lipase-catalyzed synthesis OFN-trans-feruloyltyramine using response surface methodology (RSM),” Chemical Engineering Communications, vol. 201, no. 12, pp. 1582–1592, 2014. View at: Publisher Site | Google Scholar
  20. Y. Feng, Y. J. Cheng, J. Peng et al., “Optimization of the synthesis process of 2-(3-hydroxy-1-adamantyl)-2-oxoacetic acid by the central composite design-response surface methodology,” Chemical Research & Application, vol. 25, no. 2, pp. 194–199, 2013. View at: Google Scholar
  21. S. L. C. Ferreira, R. E. Bruns, E. G. P. da Silva et al., “Statistical designs and response surface techniques for the optimization of chromatographic systems,” Journal of Chromatography A, vol. 1158, no. 1-2, pp. 2–14, 2007. View at: Publisher Site | Google Scholar
  22. W.-M. Cheng, R. Shang, H.-Z. Yu, and Y. Fu, “Room-temperature decarboxylative couplings of α-oxocarboxylates with aryl halides by merging photoredox with palladium catalysis,” Chemistry—A European Journal, vol. 21, no. 38, pp. 13191–13195, 2015. View at: Publisher Site | Google Scholar
  23. Q. W. Wang, Y. Y. Wei, and C. B. Yue, “Preparation of 3-methyl-4-nitrobenzoic acid via oxidation of 2,4-dimethylnitrobenzene in presence of phase transfer catalyst,” Speciality Petrochemicals, vol. 24, no. 1, pp. 26–29, 2007. View at: Google Scholar
  24. N. Zhang, J. Xie, and V. K. Varadan, “Functionalization of carbon nanotubes by potassium permanganate assisted with phase transfer catalyst,” Smart Materials and Structures, vol. 11, no. 6, pp. 962–965, 2002. View at: Publisher Site | Google Scholar
  25. R. Gan, J. Zhou, J. Li, M. Zhang, X. Jiang, and X. Hu, “An improved synthetic method of saxagliptin intermediate 3-hydroxy-1- acetyladamantane and its characterization,” Letters in Organic Chemistry, vol. 13, no. 7, pp. 514–518, 2016. View at: Publisher Site | Google Scholar
  26. F. Liu, W. Yu, J. Zhang et al., “A novel method for the synthesis of 2-(3-hydroxy-1-adamantyl)-2-oxoacetic acid,” Journal of Chemical Research, vol. 37, no. 12, pp. 722-723, 2013. View at: Publisher Site | Google Scholar

Copyright © 2019 Qi Liao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.